1. Home
  2. PPSI vs LEXX Comparison

PPSI vs LEXX Comparison

Compare PPSI & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Power Solutions Inc.

PPSI

Pioneer Power Solutions Inc.

HOLD

Current Price

$3.70

Market Cap

38.6M

Sector

Industrials

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.57

Market Cap

22.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPSI
LEXX
Founded
2008
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.6M
22.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PPSI
LEXX
Price
$3.70
$0.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$4.00
AVG Volume (30 Days)
52.2K
366.8K
Earning Date
11-13-2025
01-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.86
N/A
Revenue
$31,751,000.00
$705,923.00
Revenue This Year
$26.84
$13.35
Revenue Next Year
$10.26
$78.83
P/E Ratio
$1.31
N/A
Revenue Growth
105.82
52.05
52 Week Low
$2.25
$0.48
52 Week High
$5.70
$2.43

Technical Indicators

Market Signals
Indicator
PPSI
LEXX
Relative Strength Index (RSI) 42.98 28.90
Support Level $3.62 $1.05
Resistance Level $4.24 $1.44
Average True Range (ATR) 0.22 0.12
MACD -0.03 -0.06
Stochastic Oscillator 15.93 10.94

Price Performance

Historical Comparison
PPSI
LEXX

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: